Clinical Trials List
2018-10-24 - 2021-12-31
Phase I/II
Terminated4
ICD-10C22.1
Intrahepatic bile duct carcinoma
ICD-10C16
Malignant neoplasm of stomach
-
Trial Applicant
INNOPHARMAX INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
7 Stop recruiting
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20;25 participants
-
Global
37;50 participants
